Core Insights - Olin Corporation reported a profit of $42.8 million for Q3 2025, a significant recovery from a loss of $24.9 million in the same quarter last year, with earnings per share at 37 cents compared to a loss of 21 cents [1][8] - Revenue increased by approximately 7.8% year over year to $1,713.2 million, although it fell short of the Zacks Consensus Estimate of $1,731.5 million due to constrained demand growth [2][8] Segment Review - **Chlor Alkali Products and Vinyls**: Revenues reached $924 million, up around 6% year over year, but missed the consensus estimate of $992 million. Segment earnings improved to $127.6 million from $45.3 million in Q3 2024 [3] - **Epoxy**: Revenues increased by approximately 22.6% year over year to $349.6 million, surpassing the consensus estimate of $321 million [3] - **Winchester**: Revenues rose about 1.6% year over year to $439.6 million, driven by higher military sales, although it missed the consensus estimate of $448 million [4] Financials - Olin's cash balance at the end of Q3 was $140.3 million, with a net debt of approximately $2.85 billion. The company repurchased about 0.5 million shares for $10.1 million during the quarter, maintaining around $2 billion in share repurchase authorizations [5] Outlook - The company anticipates Q4 2025 adjusted EBITDA to be between $110 million and $130 million, citing seasonal weakness and ongoing market challenges. Olin emphasizes a disciplined capital allocation strategy to maximize cash generation while maintaining net debt levels [6][8] Price Performance - Olin's shares have declined by 40.6% over the past year, compared to a 25.2% decline in the industry [7]

Financial Performance - Q3 2025 - Chlor Alkali Products & Vinyls segment sales were $924 million, with adjusted EBITDA of $237 million[11, 12] - Epoxy segment sales were $350 million, with an adjusted EBITDA loss of $19 million[18] - Winchester segment sales were $440 million, with adjusted EBITDA of $33 million[24] - Olin Corporation's Q3 2025 Adjusted EBITDA was $222.4 million, compared to $176.1 million in Q2 2025 and $160.3 million in Q3 2024[60, 62] Key Highlights & Actions - Olin recognized a $32 million net benefit from Section 45V Clean Hydrogen Production tax credits in the Chlor Alkali Products & Vinyls segment[16] - Winchester is shifting production toward international military sales and lowering commercial production to reduce inventory levels[29] - The company expects to lower current debt levels, targeting year-end 2025 net debt comparable to year-end 2024[36] Outlook - Q4 2025 - Olin anticipates Q4 2025 adjusted EBITDA to be between $110 million and $130 million, including a ~$40 million penalty from planned inventory reductions[38] - The company expects caustic soda price improvement and aims to preserve ECU values despite seasonally weak demand in the CAPV segment[38] - Olin plans aggressive inventory reductions and will execute the Freeport turnaround safely and on budget[38]

Core Insights - Olin reported revenue of $1.71 billion for the quarter ended September 2025, reflecting a year-over-year increase of 7.8% [1] - The company's EPS was $0.40, a significant improvement from -$0.21 in the same quarter last year, resulting in an EPS surprise of +344.44% compared to the consensus estimate of $0.09 [1] Revenue Performance - Epoxy sales reached $349.6 million, exceeding the average estimate of $320.9 million, marking a year-over-year increase of 22.6% [4] - Chlor Alkali Products and Vinyls generated $924 million in sales, below the estimated $992.33 million, but still showing a 6% increase from the previous year [4] - Winchester sales amounted to $439.6 million, slightly below the average estimate of $448.42 million, with a year-over-year growth of 1.6% [4] Income Before Taxes - Income before taxes for Chlor Alkali Products and Vinyls was $127.6 million, surpassing the average estimate of $86.94 million [4] - Winchester's income before taxes was $19.3 million, lower than the estimated $23.86 million [4] - Epoxy reported a loss before taxes of $-32.2 million, which was worse than the average estimate of $-19.35 million [4] Stock Performance - Olin's shares returned +0.4% over the past month, underperforming the Zacks S&P 500 composite's +2.5% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance in the near term [3]

Core Insights - Olin Corporation (OLN) reported a second-quarter 2025 loss of $1.3 million, or a loss of $0.01 per share, compared to a profit of $74.2 million, or $0.62 per share, in the same quarter last year. Excluding one-time items, earnings were $0.05 per share [1][7] - Revenues increased by approximately 6.9% year over year to $1,758.3 million, surpassing the Zacks Consensus Estimate of $1,669.1 million [1][7] Segment Review - **Chlor Alkali Products and Vinyls**: Revenues reached $979.5 million, up around 6.4% year over year, exceeding the consensus estimate of $955.4 million. Segment earnings were $64.9 million, down from $99.3 million in Q2 2024 [2] - **Epoxy**: Revenues rose approximately 4.2% year over year to $331.2 million, beating the consensus estimate of $305.9 million [3] - **Winchester**: Revenues increased by about 10.2% year over year to $447.6 million, driven by higher military sales, surpassing the consensus estimate of $401.9 million [3] Financials - Olin's cash balance at the end of Q2 was $223.8 million, with a net debt of approximately $2.8 billion. The company repurchased around 0.5 million shares for $10.1 million during the quarter, with about $2 billion remaining in share repurchase authorizations [4] Outlook - Olin anticipates adjusted EBITDA for Q3 2025 to be between $170 million and $210 million, citing ongoing market challenges and potential rising costs. The company emphasizes a disciplined capital allocation strategy focused on maximizing cash generation [5] Price Performance - Olin's shares have declined by 54.1% over the past year, compared to a 19.4% decline in the industry [6]

Core Viewpoint - Olin Corporation reported a significant decline in net income for the first quarter of 2025, with adjusted earnings surpassing expectations despite lower overall revenues and EBITDA [1][2]. Financial Performance - Net income for Q1 2025 was $1.4 million, down from $48.6 million in the prior-year quarter [1]. - Adjusted earnings were 4 cents per share, beating the Zacks Consensus Estimate of a loss of 10 cents [1]. - Adjusted EBITDA decreased to $185.6 million from $242.1 million year-over-year [1]. Revenue Analysis - Total revenues for Q1 2025 were $1,644.2 million, slightly missing the Zacks Consensus Estimate of $1,661.2 million but showing a year-over-year increase of approximately 0.54% [2]. - Chlor Alkali Products and Vinyls segment revenues rose to $924.5 million, a 4.5% increase year-over-year, exceeding the consensus estimate of $923 million [2]. - Epoxy segment revenues fell by about 2.8% to $331.7 million, surpassing the consensus estimate of $329 million [3]. - Winchester segment revenues declined by approximately 5.2% to $388 million, missing the consensus estimate of $410 million [3]. Cash Flow and Share Repurchase - The company repurchased 0.7 million shares for $20.2 million during the quarter [4]. - Cash flow from operating activities turned negative, with an outflow of $86 million compared to an inflow of $81 million in the prior year [4]. Future Outlook - For Q2 2025, Olin expects results from its Chemicals businesses to remain similar to Q1, with anticipated adjusted EBITDA between $170 million and $210 million [5][6]. - The company forecasts improved performance in the Winchester unit due to seasonal demand and military sales [5]. Stock Performance - Olin's stock has experienced a 63.1% decline over the past year, compared to a 28.3% decline in the industry [7].